Clinical Trial Update: Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for lenvatinib after liver transplantation in patients with hepatocellular carcinoma and portal vein tumor thrombus (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Tumor Thrombus

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: RenJi Hospital | Conditions: Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | Phase 2, Phase 3 | Status: UNKNOWN